3D bioprinting as an emerging standard for cancer modeling and drug testing
Neoplastic diseases are a leading cause of death worldwide accounting for 10 million mortalities in 2020. Despite constantly revised and improved therapeutic regimens, the number of fatal cases increases annually. Therefore, better preclinical models are needed to study tumorigenesis and assess new...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2022-08-01
|
| Series: | Folia Medica |
| Online Access: | https://foliamedica.bg/article/73419/download/pdf/ |